Aurora Cannabis repays remainder of convertible senior debt

Aurora Cannabis says it has repaid the remaining balance of its convertible senior notes, a landmark in the Canadian producer’s efforts to cut its debt and save on interest payments.

Aurora Cannabis appoints new chief financial officer, consolidates shares

Aurora Cannabis appointed Simona King, a veteran executive of multinational pharmaceutical company Bristol Myers Squibb, as chief financial officer.

Aurora Cannabis acquires MedReleaf Australia in bigger bet on medical

Aurora Cannabis has acquired the remaining 90% equity interest of MedReleaf Australia it didn’t already own, giving the Canadian marijuana producer a bigger foothold in one of the world’s biggest federally regulated medical markets.

Aurora Cannabis seeks Nasdaq compliance via share consolidation

Canadian producer Aurora Cannabis said it’s planning to consolidate its shares to restore compliance with the Nasdaq’s minimum bid-price requirement and ensure continued access to a range of institutional investors.

Aurora Cannabis settles patent dispute with Willow Biosciences

Canadian licensed producer Aurora Cannabis has reached a settlement with Willow Biosciences over an ongoing patent litigation.

Aurora Cannabis closes bought deal financing, yielding CA$38.8 million

Canadian producer Aurora Cannabis received gross proceeds of 38.8 million Canadian dollars ($28.3 million) from a bought deal offering after the underwriters’ over-allotment option was fully exercised.

Aurora shuttering Reliva CBD unit as exports help narrow loss

A significant jump in plant-propagation sales and medical marijuana exports helped Canadian licensed producer Aurora Cannabis narrow its loss in the first quarter of fiscal year 2024 to 28.3 million Canadian dollars ($20 million).

Aurora Cannabis sells Sun production facility to Bevo Farms

Canadian marijuana producer Aurora Cannabis closed on the sale of its enormous Sun greenhouse to Bevo Farms, although the exact value of the transaction was not disclosed.

Aurora Cannabis reports CA$87 million loss, aims for positive free cash flow

Aurora Cannabis reported a loss of 87 million Canadian dollars ($65 million) for the three months ended March 31, 2023, up slightly from the CA$67.2 million net loss reported in the previous quarter.

Aurora Cannabis closing production facility in Denmark

Canadian producer Aurora Cannabis is closing its remaining facility in Denmark and moving production to Canada in a bid to lower costs.

Aurora Cannabis warned by Nasdaq about low stock price

Aurora Cannabis has been notified by the Nasdaq that it does not meet the stock exchange’s listing standards after its stock price fell below the $1 minimum bid price requirement for 30 days in a row.

Aurora Cannabis CEO’s ‘transformation’ of company offers lessons for rivals

Aurora Cannabis CEO Miguel Martin discusses his role in the “transformation” of the company from a money-losing venture to one on the upswing.